))
Episode 26. Management of Newly Diagnosed Hodgkin's Lymphoma
Manage episode 371449566 series 3369804
Innhold levert av Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
In this episode, we delve into the history of frontline treatment in young/fit patients with Hodgkin's lymphoma and recent developments in the past decade with Dr. Nancy Bartlett from Washington University.
Link for our Blood Cancer Talks Survey: https://bit.ly/BCTS
Here are the key trials we discussed:
1. RATHL Trial (PET-adapted treatment of Advanced Hodgkin’s Lymphoma):
https://pubmed.ncbi.nlm.nih.gov/27332902/
2. S0816 (PET-adapted treatment of Advanced Hodgkin’s Lymphoma):
https://pubmed.ncbi.nlm.nih.gov/27069074/
3. ECHELON-1 (Replacing Bleomycin by Brentuximab Vedotin in Advanced Hodgkin’s Lymphoma):
https://pubmed.ncbi.nlm.nih.gov/29224502/
https://pubmed.ncbi.nlm.nih.gov/35830649/
4. BREACH (BV-AVD vs ABVD for Early Stage Unfavorable Hodgkin’s Lymphoma):
https://pubmed.ncbi.nlm.nih.gov/35867960/
5. S1826 (Nivo-AVD vs BV-AVD in Advanced Hodgkin’s Lymphoma):
https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.17_suppl.LBA4
6. FIL-ROUGE (PET-adapted ABVD vs Dose-Intensified ABVD):
https://onlinelibrary.wiley.com/doi/10.1002/hon.3163_4
7. HD21 (BRECADD vs EBEACOPP in Advanced Hodgkin’s Lymphoma):
47 episoder
Del
